Navigation Links
Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
Date:4/14/2008

NEW YORK, April 14 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine -- a naturally occurring chemical that gives rise to urate in the body -- to slow or stop the progression of Parkinson's disease.

The work is being funded under the Foundation's LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) 2007 initiative. LEAPS 2007 was funded with a lead gift from the Edmond J. Safra Foundation, one of the most steadfast supporters of The Michael J. Fox Foundation since its inception.

Urate is a natural metabolite and major antioxidant in humans. Previous studies found that healthy people with higher urate levels in the blood had a reduced risk of developing PD. More recent work, including a study published today in the journal Archives of Neurology authored by two of the principal investigators on this LEAPS award, have linked higher urate levels to a possible slower progression of the disease.

The goals of this LEAPS award are to determine the safety of using inosine to raise urate levels, and to assess optimal dosage for therapeutic effect. Ninety people recently diagnosed with Parkinson's disease will be enrolled in a randomized, double-blind clinical trial to determine whether and at what dose inosine can safely elevate levels of urate in cerebrospinal fluid. Three months after enrollment, cerebrospinal fluid will be tested for urate levels. If a tolerable dose of inosine adequately increases urate in the cerebrospinal fluid, subjects will continue on treatment for up to two years to assess long-term safety.

"This project is precisely the sort of work that The Michael J. Fox Foundation exists to identify and drive forward for patients' benefit," said Katie Hood, the Foundation's CEO. "The study is based on interesting epidemiological observations, but because inosine is a publicly available compound, no corpo
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
2. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
3. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
4. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
5. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
6. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
7. Gates Foundation Seeks Proposals for Innovative Global Health Research
8. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
9. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
10. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
11. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, Medical Oxygen Systems ...reportlinker.com/p0164334/Medical-Oxygen-Systems--... medical oxygen systems market for home healthcare...s. The buoyant growth expectations stem from demog...
(Date:12/1/2009)...N.J., Dec. 1 Johnson & Johnson... announced today that it has submitted a New Drug ...stration (FDA) for tapentadol extended release (ER...he management of moderate to severe chronic pain i...c pain, defined as pain that persists for long per...
(Date:12/1/2009)...STATION, N.J., Dec. 1 Merck & ...rug Administration (FDA) has approved ZEGERID OTC(...apsules), for over-the-counter treatment of freque...he-counter by Schering-Plough HealthCare Products,...amp; Co., Inc. Schering-Plough and Merck merged on...
Breaking Medicine Technology:Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Interventional radiology resources cover peripheral arterial disease 56584 1Interventional radiology resources cover peripheral arterial disease 56584 2Interventional radiology resources cover peripheral arterial disease 56584 3Toward a nanomedicine for brain cancer 9839 1ACLA Opposes Proposed LabTax 56582 1ACLA Opposes Proposed LabTax 56582 2
... by Medical Research Council, LEXINGTON, Mass., A...EV ) announced today the completion of,enrollment ... PRO 2000, the,Company,s candidate vaginal microbi...transmitted infections. The trial is sponsored by ...) and conducted by the Microbicides,Development Pr...
...ciences, Inc. (Nasdaq: HGSI ) today announced tha...ng of patients in a randomized Phase 2 trial of,HG...therapy agents,paclitaxel and carboplatin as first...er (NSCLC)., (Logo: http://www.newscom.com/cgi-b...medical need for effective treatment options for,n...
Other Medicine Technology:Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5
(Date:12/2/2009)... A team of Kendall Hunt authors earned the ...d at the recent National Association for Gifted Ch...ember 5-7, 2009. , Dubuqu...l Hunt authors earned the 2009 Gifted Child Quarte... Association for Gifted Children’s annual co...
(Date:12/2/2009)...TA, Dec. 2 In response to rising s... FamilyLife, a non-profit ministry dedicated to su... Weekend to Remember® marriage conference at...anta from Dec. 11 - 13 at the Grand Hyatt Atlanta ... Remember is a marriage getaway aimed at strength...
(Date:12/2/2009)...illion - 4 State Campaign Features Small Business ...esses and Would Kill Jobs ,, WASHINGTON, Dec. ...e jobs summit scheduled for Thursday, Keeping Smal... Liberty, today announced a new $1 million 4 state...of the current health care legislation on small bu...
(Date:12/2/2009)...S ANGELES, Dec. 2 At a ...Tourism ministerial delegates came together to out...equired to give it the necessary thrust. Organized...edicaltourismassociation.com , the high-powered co...iscussed the opportunities and requests for assist...
(Date:12/2/2009)..., KANSAS CITY, Mo., Dec. 2 Lock...omprehensive, practical view on proposed health re... (Logo: http://www.newscom.com/cgi-bin/prnh/20090...od, bad, and ugly in the legislation, according to...on Benefit Group,s Compliance Services Division ...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2
... Students and Professors Honored for Their Researc... 12,outstanding Ph.D. students and two professors ...or research accomplishments in the field of organi...c,chemistry in pharmaceutical discovery. This year...
... 14 On Sunday, June 29,2008, West Coast Bank will... (ALAO) Reach the Bridge Run, Portland,s most uniq...choose their own start times, but must reach the,B...roads of Forest Park., West Coast Bank Relationsh...
...r of the International Association of Business Com...n of The University of Texas Medical School at Hou...prestigious award was given April 24 at the organi...nce in leadership , management, and communication ...
...heKnows.com,( http://www.SheKnows.com ), one of th...nnounced today the acquisition of PregnancyandBaby... online community for women from,preconception thr...offers a,comprehensive collection of articles, int...
...equired for Immediate Needs, NEW YORK, May 14 Tw...n a generation, news of its full impact on the,com...ickling in at a,painfully slow speed., According ...f villages and small towns were almost completely ...
...eadings rise, urges broader public action to curb ...ews) -- Just a few hours of exposure to particulat... and harm blood vessel function within 24 hours, a...roke, the researchers said. , Particulate matter (...
Other Medicine News:Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 3Health News:UT Houston Dean Colasurdo named Executive Communicator of the Year 2Health News:SheKnows Acquires PregnancyandBaby - Online Community From Preconception Through Birth 2Health News:UNICEF Rushing Medical Supplies, Tents, Clean Water to Children Affected by Powerful Earthquake in China 2Health News:Pollution Particles Impair Blood Vessel Function 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: